HR 4541 – Reauthorizing the Young Women’s Breast Health Education and Awareness Act
Data as of August 28, 2026 · Refresh this data →
Sponsored by Rep. Wasserman Schultz, Debbie [D-FL-25] · 20 cosponsors
Plain-English Summary
This bill reauthorizes and revises programs of the Centers for Disease Control and Prevention (CDC) that support services and education addressing breast and cervical cancer. The bill reauthorizes through FY2030 and makes changes to the CDC’s National Breast and Cervical Cancer Early Detection Program. This program provides grants to states for breast and cervical cancer screening, diagnostic, and treatment services for individuals who have low incomes, are uninsured, or otherwise lack access to such services. The bill increases flexibility in how states may spend grant funds under the program. The Government Accountability Office must report to Congress on the work of the National Breast and Cervical Cancer Early Detection Program, including the number of individuals served and barriers to accessing screenings. Also, the bill reauthorizes through FY2031 CDC programs relating to young women’s awareness of breast health and breast cancer. These programs include campaigns to educate young women and health care professionals, research on preventing breast cancer in younger women, and grants for resources and services to young women diagnosed with breast cancer and precancerous conditions.
Current Status
Received in the Senate.
What Problem This Addresses
Low‑income, uninsured, and underinsured individuals continue to face barriers to breast and cervical cancer screening, diagnosis, and treatment. Existing CDC programs require reauthorization to maintain grant funding and to expand flexibility for state implementation. Young women’s awareness of breast health remains uneven, prompting a need for continued education and research initiatives.
Outlook
The bill passed the House on July 20, 2026 with a 394‑6 vote and was referred to the Senate on July 21, 2026. It is currently awaiting Senate consideration, and its ultimate enactment depends on further legislative action. This assessment reflects the bill’s present procedural position, not a guarantee of passage.
Arguments From Supporters
Sponsor Rep. Wasserman Schultz and co‑sponsors argue that reauthorizing the National Breast and Cervical Cancer Early Detection Program will sustain vital services for vulnerable populations. They emphasize that increased grant flexibility can improve state-level responsiveness to screening barriers. The bill also aims to enhance education and research targeting breast cancer in younger women, which supporters cite as a public‑health priority.
Arguments From Opponents
No organized opposition to H.R. 4541 is evident in the public record or committee reports as of the latest actions.
Where Both Sides Agree
Both supporters and the House Energy and Commerce Committee agree that breast and cervical cancer screening is a public‑health need and that federal support is justified. There is consensus that young women’s breast‑health education warrants continued funding.
Core Disagreement
Debate in the House highlighted differing views on the extent of grant‑spending flexibility and the specific fiscal allocations through FY2030‑31. Some members raised procedural concerns about the suspension‑of‑the‑rules process, though substantive policy disagreement was limited.
Constitutional Basis Cited
The sponsor cites Article I, Section 8 of the U.S. Constitution, which grants Congress authority to enact legislation on the subject, as recorded in the Congressional Record (Vol. 171, No. 123, July 17, 2025). This constitutional basis aligns with Congress’s power to fund public‑health programs.
Economic Considerations
If enacted, the bill could generate cost savings by early detection, reducing expensive late‑stage cancer treatments, though precise fiscal outcomes are uncertain. The increased flexibility for state grant use may improve program efficiency, but the net budgetary impact will depend on future appropriations and implementation choices.
Sections beyond the plain-English summary are AI-synthesized analysis based on the sourced legislative record from Congress.gov, read, edited where needed, and approved by a human editor before publication. Full methodology: Editorial & Methodology.
← All Records